Terms: = Endocrine gland cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2
230 results:
1. Exosomal HSPB1, interacting with FUS protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing nrf2 mRNA and repressing P450.
Zhang L; Yang L; Du K
J Cell Mol Med; 2024 May; 28(9):e18209. PubMed ID: 38682349
[TBL] [Abstract] [Full Text] [Related]
2. Chelerythrine induces apoptosis and ferroptosis through nrf2 in ovarian cancer cells.
Zhou J; Wang Y; Fu Y; Lin Z; Lin H; Lv G; Kong N; Xin G; Zhou F; Qiu Z; Huang X
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):174-181. PubMed ID: 38650145
[TBL] [Abstract] [Full Text] [Related]
3. Therapeutic potential of targeting nrf2 by panobinostat in pituitary neuroendocrine tumors.
Cheng Y; Dai Y; Tang H; Lu X; Xie J; Xie W; Zhang Q; Liu Y; Lin S; Yao H; Shang H; Yang K; Liu H; Wu X; Zhang J; Zhang X; Xue L; Wu ZB
Acta Neuropathol Commun; 2024 Apr; 12(1):61. PubMed ID: 38637883
[TBL] [Abstract] [Full Text] [Related]
4. ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic cancer Cells.
Takasaki T; Hamabe Y; Touchi K; Khandakar GI; Ueda T; Okada H; Sakai K; Nishio K; Tanabe G; Sugiura R
Oxid Med Cell Longev; 2024; 2024():7683793. PubMed ID: 38500550
[TBL] [Abstract] [Full Text] [Related]
5. Targeting nrf2 to treat thyroid cancer.
Gong Z; Xue L; Li H; Fan S; van Hasselt CA; Li D; Zeng X; Tong MCF; Chen GG
Biomed Pharmacother; 2024 Apr; 173():116324. PubMed ID: 38422655
[TBL] [Abstract] [Full Text] [Related]
6. Synergistic suppression of ovarian cancer by combining nrf2 and GPX4 inhibitors: in vitro and in vivo evidence.
Li N; Jiang X; Zhang Q; Huang Y; Wei J; Zhang H; Luo H
J Ovarian Res; 2024 Feb; 17(1):49. PubMed ID: 38396022
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-320a enhances LRWD1 expression through the AGO2/FXR1-dependent pathway to affect cell behaviors and the oxidative stress response in human testicular embryonic carcinoma cells.
Lin YH; Su CH; Chen HM; Wu MS; Pan HA; Chang CN; Cheng YS; Chang WT; Chiu CC; Teng YN
Aging (Albany NY); 2024 Feb; 16(4):3973-3988. PubMed ID: 38385979
[TBL] [Abstract] [Full Text] [Related]
8. β-Sitosterol targets ASS1 for nrf2 ubiquitin-dependent degradation, inducing ROS-mediated apoptosis via the PTEN/PI3K/AKT signaling pathway in ovarian cancer.
Wang H; Liu J; Zhang Z; Peng J; Wang Z; Yang L; Wang X; Hu S; Hong L
Free Radic Biol Med; 2024 Mar; 214():137-157. PubMed ID: 38364944
[TBL] [Abstract] [Full Text] [Related]
9. CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/nrf2 axis in pancreatic cancer.
Tuerhong A; Xu J; Wang W; Shi S; Meng Q; Hua J; Liu J; Zhang B; Yu X; Liang C
Surgery; 2024 May; 175(5):1264-1275. PubMed ID: 38302326
[TBL] [Abstract] [Full Text] [Related]
10. A Morpholine Derivative N-(4-Morpholinomethylene)ethanesulfonamide Induces Ferroptosis in Tumor Cells by Targeting nrf2.
Sun B; Zhang L; Wu B; Luo X
Biol Pharm Bull; 2024 Feb; 47(2):417-426. PubMed ID: 38296488
[TBL] [Abstract] [Full Text] [Related]
11. Role of SLC7A11/xCT in Ovarian cancer.
Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
[TBL] [Abstract] [Full Text] [Related]
12. DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.
Bildik G; Gray JP; Mao W; Yang H; Ozyurt R; Orellana VR; De Wever O; Carey MS; Bast RC; Lu Z
Autophagy; 2024 Mar; 20(3):675-691. PubMed ID: 38169324
[TBL] [Abstract] [Full Text] [Related]
13. Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting nrf2.
Gong Z; Xue L; Vlantis AC; van Hasselt CA; Chan JYK; Fang J; Wang R; Yang Y; Li D; Zeng X; Tong MCF; Chen GG
J Endocrinol Invest; 2024 May; 47(5):1271-1280. PubMed ID: 38062319
[TBL] [Abstract] [Full Text] [Related]
14. SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic cancer.
Kim MJ; Kim HS; Kang HW; Lee DE; Hong WC; Kim JH; Kim M; Cheong JH; Kim HJ; Park JS
Cells; 2023 Oct; 12(20):. PubMed ID: 37887353
[TBL] [Abstract] [Full Text] [Related]
15. nrf2 interacts with distal enhancer and inhibits nitric oxide synthase 2 expression in KRAS-driven pancreatic cancer cells.
Di Giorgio E; Cortolezzis Y; Gualandi N; Agostini F; Rapozzi V; Xodo LE
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119606. PubMed ID: 37852325
[TBL] [Abstract] [Full Text] [Related]
16. Zinc Finger 521 Modulates the nrf2-Notch Signaling Pathway in Human Ovarian Carcinoma.
Scicchitano S; Faniello MC; Mesuraca M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834202
[TBL] [Abstract] [Full Text] [Related]
17. Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells.
Wang Y; Xie L; Liu F; Ding D; Wei W; Han F
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117299. PubMed ID: 37816474
[TBL] [Abstract] [Full Text] [Related]
18. Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors.
Wang X; Su S; Zhu Y; Cheng X; Cheng C; Chen L; Lei A; Zhang L; Xu Y; Ye D; Zhang Y; Li W; Zhang J
Nat Commun; 2023 Sep; 14(1):5778. PubMed ID: 37723178
[TBL] [Abstract] [Full Text] [Related]
19. [Distal pancreatectomy with celiac axis resection for pancreatic body cancer: a single center review of 89 consecutive cases].
Huang XM; Zhang K; Yin J; Wu PF; Cai BB; Lu ZP; Tu M; Chen JM; Guo F; Xi CH; Wei JS; Wu JL; Gao WT; Dai CC; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2023 Oct; 61(10):894-900. PubMed ID: 37653992
[No Abstract] [Full Text] [Related]
20. USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing nrf2.
Cui J; Guo Y; Yin T; Gou S; Xiong J; Liang X; Lu C; Peng T
Biomed Pharmacother; 2023 Oct; 166():115359. PubMed ID: 37639742
[TBL] [Abstract] [Full Text] [Related]
[Next]
